Chapter 18 Flashcards

(568 cards)

1
Q

What are the serum measurements for hepatocyte integrity

A

Aspartate aminotransferase (AST)

Alanine aminotransferase (ALT)

Lactate dehydrogenase (LdH0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the tests that look for biliary excretory function

A

Serum bilirubin

Ruin bilirubin

Serum bile acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the tests that look for damage to the bile canaliculus

A

Serum alkaline phosphatase

Serum gamma-glutamic transpeptidase (GGT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the tests that look for hepatocyte synthetic function

A

Serum albumin

Coagulation factors, PT, PTT, fibrinogen, prothrombin, factors V, VII, IX, and X

Hepatocyte metabolism: serum ammonia aminopyrine breath test (hepatic demethylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Reversible changes in hepatocytes

A

Steatosis

Cholestasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is steatosis

A

Accumulation of bilirubin in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cholestasis

A

Accumulation of bilirubin in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does hepatocyte necrosis occur

A

Fluid flows into the cell, the cell swells, and ruptures (lysis) when osmotic regulation is interrupted

Bless also form to carry off intracellular stuff to the extracellular

Macrophages cluster at these sites of injury

Predominate mode of death in ischemic/hypoxic injury

Significant part of the response to oxidative stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hepatocyte apoptosis

A

Hepatocyte shrinkage, nuclear chromatin condensation(pkynosis), fragmentation (karyorrhexis) and cellular fragmentation into acidophilus apoptotic bodies

AKA

Acidophil bodies: apoptotic hepatocytes so named due to their deeply eosinophilic stain
-COUNCILMAN BODIES: YELLOW FEVER(SAME THIN, HISTORICAL TERM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CONFLUENT NECROSIS INT HE LIVER

A

WIDESPREAD PARENCHYMAL LOSS; SEVERE, ZONAL LOSS OF HEPATOCYTES

MAY BEGIN AS A ZONE OF HEPATOCYTE DROPOUT AROUND THE CENTRAL VEIN

PRODUCE A SPACE FILLED WITH CELLULAR DEBRIS, MACROPHAGES, AND REMNANTS OF THE RETICULAR MESHWORK

SEEN IN ACUTE TOXIC INJURY, ISCHEMIC INJURIES OR VIRAL/AUTOIMMUNE HEPATITIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bridging necrosis in the liver

A

This zone links central veins to portal tracts or bridges portal tracts

Vascular insult leads to parenchymal extinction due to large areas of contiguous hepatocyte death

Collapse of supporting framework can occur

Cirrhosis may result

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Regeneration in the liver

A

Mitosis replication adjacent to those that have died, even when there is significant confluent necrosis

Stem cell like: hepatocytes an replicate even in the setting of chronic injury
-stem cell replenishment is not a significant part of parenchymal repair

Severe forms of acute liver failure activates the primary intrahepatic stem cell niche (canal of hearing)
-contribution unclear

Ductal reactions : when hepatocytes in patients with chronic disease reach replication senescence and clear evidence of stem cell activation appears

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Scar deposition in the liver

A

Principle cell type involved in scar deposition is the fat containing, myofibroblastic hepatic stellate cell

Quiescent form:stores lipid and vitamin A (fat soluble)

Injury: activated and converted to highly fibronectin myofibroblasts

  • cytokines released by Kupfer cells and lymphocytes: TGFB, MMP-2 (metaloproteinase-2), and TIMP-1 and 2 (tissue inhibitors of metalloproteinases 1 and 2).
  • contraction stimulated by endothelin1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is scar deposition in liver reversible

A

If the injurious agent is eliminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fibrous septa development in the liver

A

Collapse of reticular where large swaths of hepatocytes have disappeared and stellate cells are activated

Regenerating hepatocytes become surrounded in late chronic disease leads to diffuse scarring (cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hepatic failure

A

Hepatic failure ensures when 80-90% of the functional capacity of the liver is lost
80% mortality without transplant

May be due to acute injury, chronic progressive injury, or acute on chronic injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is acute hepatic failure

A

Occurs within 26 weeks (6 months) of initial injury

Absence of preexisting liver disease

Associated with encephalopathy and coagulopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Causes of acute hepatic failure

A

-massive hepatic necrosis, a result of drugs/toxins

Acetaminophen (50% onset within one week) hepatitis A, autoimmune hepatitis

Hepatitis B
Hepatitis C, cryptogenic

Drugs/toxins, hepatitis D

Hepatitis E, esoteric causes (wilson disease, buds-chiaroscuro)

Fatty change of the microvesicular type (fatty liver of pregnancy, valproate, tetracycline, Reye’s syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Morphology acute hepatic failure

A

-massive hepatic necrosis leads to broad regions of parenchymal loss surrounding areas of regenerating hepatocytes

Small shrunken liver

Early scarring may occur in weeks-moths

Diffuse microvesicular steatosis: diffuse poisoning of liver cells without obvious cell death and parenchymal collapse; related to fatty liver of pregnancy or idiosyncratic reactions to toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What does a patient initially present with with acute hepatic failure

A

Nausea, vomiting, and jaundice which progresses to a life threatening encephalopathy and coagulation defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Patients with acute hepatic failure and liver transaminases

A

Moderate increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why do people with acute hepatic failure gethepatomegalt

A

Hepatocyte swelling, infiltrates and edema initially
Eventually there is a shrunken liver as the parenchyma is destroyed
Decline in serum transaminases is an indication of fewer viable hepatocytes ,not recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prognosis acute hepatic failure

A

Poor prognosis
Decrease in liver enzymes, indicating few remaining hepatocytes, confirmed with worsening jaundice, coagulopathy and encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sequelae acute hepatic failure

A

Jaundice and icterus: yellowing of skin , sclera and mucus membranes

Cholestasis: systemic retention of not only bilirubin but also other solutes eliminated in bile which increases the risk of life threatening bacterial infection

Hepatic encephalopathy: due to increased serum ammonia that ranges from subtle behavioral abnormalities to marked confusion and stupor to deep coma and death

  • rigidity and hyperreflexia
  • asterixix is a characteristic sign

Coagulopathy: impaired clotting due to lack of production of vitamin K dependent (II, VII, IX, and X) and independent clotting factors

  • easy bruising-early sign
  • can lead to intracranial bleeding->herniation->death

Disseminated intravascular coagulation-liver is responsible for removing activated coagulationfrom the circulation

Portal hypertension:intrahepatic obstruction most likely; leads to ascites and hepatic encephalopathy

Hepatorenal syndrome: form of renal failure in individuals with liver failure in whom their kidneys are morphologically and functionally normal

  • na retention , impaired free water excretion, decreased renal perfusion, and decreased glomerular infiltration rate
  • decreased renal perfusion pressure due to systemic vasodilation, activation of renal sympathectomy nervous system (afferent arteriole vasoconstriction), increased RAAS activation->decrease GFR
  • onset-hypo-nutria, elevated BUN creatinine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Asterixis
Characteristic sign of acute hepatic failure Nonrhythmic, rapid extension flexion of the head and extremities Seen with arms in extension and dorsiflexied wrists
26
Chronic liver failure
Associated with cirrhosis though not mutually exclusive Chronic hepatitis B and C, non alcoholic fatty liver disease, alcoholic fatty liver disease
27
The ultimate cause of death in chronic liver failure is the same as in __ ___ ___
Acute liver failure
28
Ultimate cause of death from acute and chronic liver failure
Hepatic encephalopathy Bleeding from esophageal varices Bacterial infections
29
Cirrhosis
Diffuse transformation of the entire liver into regenerative parenchymal nodules surrounded by fibrous bands and variable degrees of vascular (portosystemic) shunting No single cirrhosis, but rather multiple variable cirrhosis Cirrhosis is no longer considered end stage liver disease because the fibrosis is potentially reversible with increasing numbers of effective treatments for cirrhosis causing conditions
30
Child Pugh classification of cirrhoissi
Helps monitor the decline of the patients ont he path to chronic liver failure
31
Class A (child Pugh)
Well compensated
32
Class B (child Pugh)
Partially compensated
33
Class C (child Pugh
Decompensated
34
What does stem cell activation in liver cirrhosis cause
Ductular reactions which increase with advancing stage of disease and are usually most prominent in cirrhoisis
35
Portal HTN cirrhosis decreased incidence morphology
Biopsy specimens with narrow, densely compacted fibrous septa separated by areas of intact hepatic parenchyma
36
Portal HTN increased incidence with liver cirrhosis
Broad bands of dense scar with dilated lymphatic space, less parenchyma; more likely to progress and lead to end stage disease
37
Clinical signs of cirrhosis before it becomes end stage
Only seen in 40% of patients Jaundice+pruritis Hypoalbuminemia->systemic edema Hyperammonemia Factor hepaticus:mercaptan formation Males hyper-estrogenemia due to impaired metabolism can lead to palmar erythema, spider angiopathy, hypogonadism, and gynecomastia Increased risk of developing hepatocellular carcinoma
38
Prehepatic causes of portal HTN
Obstructive thrombosis Narrowing of the portal vein before entering the liver Massive splenomegaly with increased splenic blood flow
39
Posthepatic causes of portal HTN
Severe right heart failure Constrictive pericarditis Hepatic vein outflow obstruction
40
Intrahepatic causes portal HTN
Usually due to cirrhosis Schistomiasis Massive fatty change Diffuse fibrosis granulomatous disease such as sarcoidosis Diseases effecting the portal microcirculation such as nodular regenerative hyperplasia Increased resistance to portal flow Increased portal venous flow due to hyper dynamic circulation
41
What is the most common cause of portal HTN
Cirrhosis
42
What causes increased resistance to portal flow
Contraction of vascular smooth muscle and myofibroblasts Decreased NO production Increased endothelin1, angiotensinogen, eicosanoids production Disruption of blood flow by scarring and formation and parenchymal nodules Remodeling and anastomoses impose arterial pressure on a normally low pressure system Interferes with metabolic exchange of sinusoidal blood and hepatocytes
43
What causes increased portal venous flow due to hyper dynamic circulation
Splanchnic arterial vasodilation-increased efflux into the portal venous system Due to NO, prostacyclin and TNF
44
Clinical portal HTN
Ascites Portosystemic shunt formation Congestive splenomegaly Hepatic encephalopathy
45
Ascites
Excessive fluid in the peritoneal cavity | Detectable with accumulation of 500 ml
46
85% of ascites is due to __ __
Cirrhosis
47
85% of ascites is due to__
Cirrhosis
48
What happens with long standing ascites
Seepage of peritoneal fluid through trans-diaphragmatic lymphatic channels—>hydro-thorax, espicially onthe RIGHT
49
Composition of ascites
Fluid is serous, <3mg/dl of protein (albumin) Neutrophils: suggests infection Blood:suggests disseminated intraabdominal cancer
50
What leads to ascites
Sinusoidal HTN Precolation of hepatic lymph in peritoneal cavity Splanchnic vasodilation
51
Mechanism of sinusoidal ascites
Hepatic sinusoidal HTN drives fluid into the space of disse which is drained by lymphatics Promoted by hypoalbuminemia->peripheral edema
52
What is the space of disse
Beneath the endothelial cells
53
What is found in the space of disse
Fat containing myofibroblastic hepatic stellate cells are found in the space of disse
54
Mechanism of ascites: percolation of hepatic lymph in peritoneal cavity
Normal flow is 800-1000ml; increased to 20L The thoracic duct isn’t ably to keep up and fluid leaks out->peripheral interstitial edema
55
Mechanism of ascites: splanchnic vasodilation
Causes systemic hypotension which leads to vasoconstriction RAAS activation leads to Na retention (and H2O follows) Increased perfusion pressure of the interstitial capillaries -transudation(protein poor) into the abdominal cavity
56
Portosystemic shunts
Flow is reversed from the portal into the systemic circulation where there are shared capillary bed Esophageal varices: 40% of patients with advanced cirrhosis; rupture can cause massive hematemesis with 30% mortality Falciform ligament and caput Medusa: dilated subcutaneous veins extend from umbilicus to rib margins Rectum: hemorrhoids
57
Splenomegaly
Due to long standing congestion Can cause thrombocytopenia(or pancytopenia Due to long standing congestion Can cause thrombocytopenia (or pancytopenia due to hypersplenism)
58
Hepatopulmonary syndrome
Hypoxia+dyspnea due to Ventillation/perfusion (V/Q) mismatch from rapid blood through dilated vessels with decreased time for diffusion
59
What exacerbates hepatopulmonary syndrome
Upright position due to gravity
60
What improves hepatopulmonary syndrome
Recumbent position
61
PortopulmonaryHTN
Dyspnea on excretion and clubbing Pulmonary arterial HTN in liver disease and portal HTN Excessive pulmonary vasoconstriction and vascular remodeling with concomitant portal hypertension
62
Acute on chronic liver failure
Individuals with stable, well-compensated chronic liver disease develop sudden signs of acute liver failure Commonly have established cirrhosis and extensive vascular shunting Significant amounts of parenchyma have borderline vascular supply and are vulnerable to superimposed insult
63
Short term mortality of acute on liver failure
50%
64
Hepatic A virus
Benign, self limited disease Does not cause chronic hepatitis or a carrier state Rarely lethal
65
Transmission hepatitis A
Fecal oral via contaminated water Raw or steamed shellfish that get it from human sewage contaminated seawater
66
Donated blood atrisk for HAV
No rare
67
What kind of virus is HAV
Single stranded + RNA
68
Anti-HAV immunoglobulin Ig_ are seen in the serum with onset of HAV—implies acute infection
M
69
In HAV infection as Ig_ declines, Ig_ appears implying memory
M G
70
After HAV infection Ig_ persistence for years conferring long term immunity
G
71
Clinical HAV
Mild or asymptomatic and rare after childhood
72
Hepatitis B
Infection that has a predilection for the liver and can cause a wide spectrum of disease manifestations , with most of the cases leading to asymptomatic chronic disease or clearance
73
5 different forms of HBV induced illness
Acute hepatitis with recovery and clearance of virus Non-progressive chronic hepatitis Progressive chronic disease ending in cirrhosis Acute hepatic failure with massive liver necrosis Asymptomatic, ‘healthy’ carrier state Chronically is an important precursor for hepatocelullar carcinoma
74
Transmission hepatitis b
High prevalence ares (AFrica, Asia): childbirth Intermediate prevalence: horizontal (breaks in skin/mucus membranes in children with close body contact) Low prevalence: unprotected sex, IV drug use
75
HBV viral characteristics
Partially dsDNA virus Mature virus=spherical double layered “Dane particle” with outer surfac protein+lipid envelope around an electron dense slightly hexagonal core
76
Serum markers for HBV
HBsAg Anti-HBs HBeAg, HBV-DNA and DNA polymerase Anti-HBc
77
HBsAg
Appears before the symptoms, peaks during the overt disease, and lasts for about 12 weeks *donated blood is screened for HBsAg
78
Anti-HBs Ab
Doesn’t rise until the disease is over, about the same time that the HBaAg goes away. The IgG form is what provides the immunity
79
Anti-HBs may persist for _, conferring protection-basis for current vaccination strategies using non infectious HBsAg
Life
80
HBeEg, HBV-DNA and DNA polymerase
All appear after HBsAg and indicate there is active viral replication
81
___ espicially can be used to track the disease and antibodies to it indicate the disease is about to wane
HBeAg
82
Persistent HBeAg
Indicator of continued viral replication, infectivity, and probably progression to chronic hepatitis
83
Anti-HBe antibodies
Acute infection has peaked and is on the wave
84
Anti-HBc Ab
Appears just before the onset of symptoms and shows up with increased aminotransferase levels (liver damage)
85
What is the best predictor of HBV chronicicity
Age at the time of infection Younger age-increased probability of chonicity
86
What is the main determinant of the outcome of HBV
Host immune response to the virus is the main determinant of the outcome of the infection Strong response by virus specific CD4 and CD8 interferon (IFN-y)-producing cells is associated with the resolution of acute infection
87
HBV does not cause direct hepatocyte injury-what causes injury
CD8 cytotoxic T cells attack infected hepatocytes
88
Complete cure of HBV
Difficult due to viral insertion into host DNA Limits the development of an effective immune response Virus persists in the face of rugs that impair its replication
89
Goal of treatment in chronic HBV
Slow progression of disease, reduce liver damage and prevent cirrhosis and cancer
90
How do we prevent spread of HBV
Vaccination and screening of blood donations prevents it
91
Treat HBV
Most cases are self limited and resolve without treatment
92
What percent of HBV patients Barbour chronic disease
5-10%
93
Is fulminant hepatitis common
No rare
94
Morphology HBV*
In chronic HBV, liver biopsy shows finely granular ground glass hepatocytes packed with HBsAg -cells with endoplasmic reticulum swollen by HBsAg-diagnostic hallmark
95
What is the diagnostic hallmark of HBV
Liver biopsy shows finely granular ground glass hepatocytes packed with HBsAg -cells with endoplasmic reticulum swollen by HBsAg
96
Hepatitis C virus characteristics
SsRNA virus Genomic instability+antigenic variability=no vaccine Anti-HCV igG antibodies do not confer effective immunity and re infection is possible
97
Infection and clearance HCV
More mild than HBV with most acute cases being asymptomatic, but 80-90% of patients develop chronic infection and 20% get cirrhosis Exists as closely related genetic variants inside infected patients
98
Clinical HCV
Characteristic repeated bouts of hepatic damage Persistent infection and chronic hepatitis=hallmarks of HCV infection Acute illness is generally asymptomatic chronic HCV infection==persistent elevations in serum aminotransferases -wax and wane, but never normal Cryoglobulinemia is found in 35% of individuals with chronic hepatitis C infection
99
Diagnose HCV
HCV RNA is detected in blood for 13 weeks during active infection with concurrent increase in aminotransferase levels (will see the increase in ALT/AST chronically)
100
What is HCV associated with
``` Metabolic syndrome (genotype3) Can give rise toinsulin resistance and non alcoholic fatty liver disease ```
101
Treatment HCV
Genotype 2 and 3 have best response to treatment, espicially in patients with IL-28B gene (encodes IFN-y involved in resistance to HCV) polymorphisms -better response to IFN-a and ribavirin Newer regimens may improve prognosis
102
Morphology HCV
Leads to portal lymphoid follicle, bile duct reactive changes and lobular regions of microvesicular steatosis Bile duct injury is possible that can histologically mimic primary biliary cirrhosis (easily distinguished clinically) Chronic HCV shows lymphoid aggregates or fully formed lymphoid follicles; fatty change of scattered hepatocytes
103
Hepatitis D is dependent for its life cycle on _
HBV
104
How is HDV dependent on HBV
External coat antigen surrounds an internal “delta antigen” the only protein produced by the virus
105
A vaccine for HBV also prevents __
HDV
106
What are the setting of HDV
Co-infection Superinfection
107
How get confection HDV
HBV must become established first to provide the HBsAg necessary for development of complete HDV virions, resulting in acute hepatitis indistinguishable from acute hepatitis of HBV-only etiology
108
Prognosis HDV confection
Self limited | Followed by clearance of both viruses
109
When is there a higher rate of acute hepatitis failure with HDV coingection
In IV drug users
110
How detect coinfection with HDV
Best indicated by detection of IgM against both HDAg and HBcAg
111
Superinfection HDV
When a chronic carrier of HBV is exposed to a new inoculum of HDV get superinfection 30-50 days later Severe acute hepatitis in a previously unrecognized HBV carrier, or exacerbation of pre existing chronic hepatitis B infection
112
Acute phase superinfection HDV
Active HDV replication and suppression of HBV with high transaminase levels
113
Chronic phase superinfection HDV
HDV replication decreases , HBV replication increases, transferase levels fluctuate, and disease progresses to cirrhosis and sometimes hepatocellular carcinoma
114
Lab values superinfection HDV
HBsAg present in serum, anti HDV persist for months or longer
115
Who gets HDV
Western countries: largely restricted to IV drug users and those who have had multiple blood transfusions
116
Clinical HDV
HDV RNA is detectable in the blood and liver just before and in the early days of acute symptomatic disease
117
Ig_ anti-HDV is the msot reliable indicator of a recent HDV exposure
M
118
How get HEV
Enterically transmitter, water borne infection Zoonotic=animal resivoirs(increased risk with exposure to monkeys, cats, pigs, and dogs)
119
Who gets HEV
Occurs primarily in young to middle aged adults
120
HEV causes 30-60% of sporadic acute hepatis in ___(more than HAV)
India
121
Characteristic feature HEV
Higher mortality rate among pregnant women-almost 20%
122
Treat HEV
Self limiting
123
What is HEV not associated with
Chronic liver disease or persistent fire is in immunocompentent patients
124
In HEV virions are shed in __ during the acute illness
Stool
125
What type of virus i HAV
SsRNA
126
What type of virus is HBV
Partially dsDBA
127
What kind of virus is HCV
SsRNA
128
What type of virus in HDV
Circular defective SsRNA
129
What type of virus is HEV
SsRNA
130
What family is HAV in
Hepatovirus (picornavirus)
131
What family is HBV in
HepaDNAvirus
132
What family is HCV
Flaviviridae
133
What family is HDV
Subviral particle in deltavirdae family
134
What family is HEV
Hepevirus
135
Transmission HAV
Fecal-oral (contaminated H2O)
136
Transmission HBV
Parenteral, sexual contact, perinatal
137
What family is HCV
Parenteral, intranasal cocaine
138
Family HDV
Parenteral
139
Family HEV
Fecal oral
140
Incubation HAV
2-6 weeks
141
HBV incubation
2-26 weeks (avg 8)
142
HCV incubation
4-26 weeks (avg9)
143
HDV incubation
2-26 weeks (avg 8)
144
HEV incubation
4-5 weeks
145
HAV progression to chronic
Never
146
HBV progression to chronic
5-10%
147
HCV progression to chronic
>80%
148
HDV progression to chronic
10% coinfection 90-100% superinfection
149
HEV progression to chronic
Never
150
Diagnosis HAV
IgM antibodies
151
HBV diagnosis
HBsAg, antiHBcAg; PCR for DNA
152
HCV diagnosis
PCR for DNA, Elisa for Ab
153
HDV diagnosis
IgM and IgG antibodies; HDV RNA serum; HDAg in liver
154
Diagnosis HEV
Serum IgM and IgG; PCR for HEV RNA
155
Which hepatitis show fulminant
A, B, D
156
Which hepatitis fulminant in pregnant women
HEV
157
Clinicopathological syndromes of hepatitis
Acute asymptomatic infection with recovery (serologic evidence only) Acute symptomatic hepatitis with recovery (anicteric or interic) Chronic hepatitis Acute liver failure Carrier state
158
Acute asymptomatic infection with recovery (serologic evidence only)
Worldwide, HAV, and HBV infections are frequently subclinical events in childhood verified only in adulthood by the resented of anti-HAV or anti HBV antibodies
159
Acute symptomatic hepatitis with recovery (anicteric or icteris) four phases
Incubation(peak infectivity during last asymptomatic days of incubation period and early days of acute symptoms) Symptomatic pre-icteric phase Symptomatic interic phase Convalescence
160
Chronic hepatitis
With progression to cirrhosis Without progression to cirrhosis
161
Acute liver failure
With massive hepatic necrosis With submissive hepatic necrosis
162
Carrier state hepatitis
“Healthy carrier’: individual with HBsAg, no HBeAg, andi HBeAg, normal aminotransferases low or undetectable serum HBV DNA, and liver biopsy showing a lack of significant infalmmation and necrosis Inactive carrier Not recognized in the United States
163
Acute hepatitis morphology
Lymphoplasmactyic (mononuclear) infiltrate Spotty necrosis or lobular hepatitis scattered throughout a lobule Necrosis empty cytoplasm , cell membrane ruptures leads to hepatocyte dropout Collapsed sinusoidal collagen reticulin framework Apoptosis; hepatocytes shrink, become eosinophilic, pyknotic, fragmented Lack of portal inflammation
164
Severe acute hepatitis morphology
CONFLUENT NECROSIS of hepatocytes around central veins Cellular debris, collapsed reticulin fibers, congestion +/- hemorrhage Variable inflammation Central portal BRIDGING NECROSIS leads to parenchymal collapse Can lead to massive hepatic necrosis/acute failure Can develop post hepatitis. Cirrhosis with abundant scarring
165
Chronic hepatitis morphology
Mononuclear portal infiltration Mild: inflammatory infiltrates are limited to portal tracts Progressive dise: extension of chronic inflammation from portal tracts with interface hepatitis Linking of orca and portal central regions=bridging necrosis Continued loss of hepatocytes=fibrous septum formation Associated hepatocyte regeneration=cirrhosis
166
What causes toxic shock syndrome
Staphylococcus aureus
167
What causes typhoid fever
Salmonella typhi
168
What causes secondary or tertiary syphilis
Treponema pallidum
169
Ascending cholangitis
Acute infalammation response within the intrahepatic biliary tree due to intrabiliary bacterial microflora during a partial or complete obstruction
170
What is autoimmune hepatitis
Chronic, progressive hepatitis Presence of autoantibodies Therapeutic response to immunosuppression
171
What triggers autoimmune hepatitis
Viral infection, drug/toxin exposure
172
Patients at risk for autoimmune hepatitis
Caucasion: DRB1* alleles (HLA association)—genetic predisposition Most frequent in white Northern Europeans Females predominance
173
What are the two types of autoimmune hepatitis
2 types based on circulating antibodies
174
Type 1 autoimmune hepatitis
Middle aged older people ANA (anti-nuclear), ASMA (anti-smooth msucle), ANTI-SLA/LP (anti-soluble liver antigen/liver-pancreas antigen), AMA (anti-mitochondrial) antibodies
175
Type 2 autoimmune hepatitis
Children and teenagers Anti-LKM1 (anti-liver kidney microsome-1) antibodies against CYP2D6 ACL1 (anti-liver cytosolic) antibodies
176
Early phase of severe parenchymal destruction followed rapidly by scarring
-fibrosis take years to develop in chronic viral hepatitis, does not develop in acute hepatitis Severe necroinfalmmatory activity indicated by interface hepatitis or parenchymal collapse Mononuclear infiltrate: plasma cells Hepatocyte ROSETTES in areas of activity
177
Early phase autoimmune hepatitis
Severe parenchymal destruction followed rapidly by scarring Fibrosis takes years to develop in chronic viral hepatitis, does not develop in acutehepatitis Severe necroinflammatory activity indicated by interface hepatitis or parenchymal collapse Mononuclear infiltrate: plasma cells Hepatocyte ROSETTES in areas of activity
178
Progressive or indolent automimmune hepatitis that lead to liver failure initial and chronic siding
Initial: severe hepatocyte injury with necrosis but little scarring Chronic: burned out cirrhosis with little necroinflammatory activity; likely due to years of subclinical disease
179
With autoimmune hepatitis, acute onset with fulminant disease in _ weeks
8
180
Autoimmune hepatitis hepatic encephalopathy
Yup
181
What happens if autoimmune hepatitis is untreated
40% mortality in 6 months Both type 1 and type 2 are likely to lead to liver failure
182
What percent of autoimmune hepatitis survivors have cirrhosisi
40%
183
Characteristic autoimmune hepatitis
Plasma cells are prominent and characteristic component of the inflammatory infiltrate in biopsy specimens showing autoimmune hepatitis
184
Prognosis autoimmune hepatitis
Between in adults than in children (delay in diagnosis in pediatric population)
185
Treat autoimmune hepatitis
80% of patients respond to immunosuppression for long term survival
186
End stage autoimmune hepatitis
Liver transplant with 75% survival at 10 years, recurrent ein 20% of patients
187
Drug or toxin liver damage
May be immediate or delayed Mild to severe Predictable (intrinsic, dose dependent) or unpredictable (idiosyncratic, multi-factorial) Due to direct toxicity, conversion of a xenobiotic to a toxin or from immune mediated toxicity Recovery usually occurs with removal of the offending agent
188
What is the most common cause of acute liver failure necessitating liver transplant in the USA
Acetaminophen
189
Why does acetaminophen cause liver failure
Due to toxic metabolite produced from the CYP450 breakdown in acinus zone 3 hepatocytes
190
What is zone 3
Closest to the terminal hepatic vein (central vein) and furthest from the portal vein Central vein turns into the hepatic vein
191
Zone 2
Tries to compensate and become injured
192
Severe acetaminophen overdose
The zone of injury extends into zone 1 (periportal hepatocytes) and this is when you start getting acute hepatic failure
193
Why can alcohol or codeine make acetaminophen
Upregulate CYP450 and make things worse
194
Chlorpromazine and liver
Cholestasis in patients who are slow to metabolize it to an innocuous byproduct
195
Halothane and liver
Fatal immune mediated hepatitis in some patents exposed on multiple occasions
196
What are the types of liver disease caused by alcohol
Hepatocellular steatosis or fatty change Alcoholic hepatitis Streatofibrosis up to and including cirrhosis (only in a small fraction) - patterns of scarring typical for all fatty liver diseases including alcohol - cirrhosis develops in only a small fraction of chronic alcoholics
197
Hepatic steatosis (fatty liver)
Microvesicular lipid droplets within hepatocytes With chronic use accumulates in microvesicular droplets which displace the nucleus Large, soft, greasy, yellow liver No fibrosis Completely reversible if patients abstains from alcohol
198
Alcoholic (steato-) hepatitis
Hepatocyte swelling (fat, H2O, proteins)+necrosis Mallory-denk bodies Neutrophilic reaction to degenerating hepatocytes, espicially those with Mallory dunk bodies
199
Mallory desk bodies
Intracellular eosinophilic aggregates of intermediate filaments (keratin 8 and 18, ubiquitin) in ballooning hepatocytes -hepatocytes are epithelial cells Mallory desk bodies==damaged intermediate filaments(in hepatocytes, cytokeratin)
200
What are Mallory denk bodies seen in
Alcoholic hepatitis, non alcoholic fatty liver disease, wilson disease, and chronic biliary tract disease
201
Mallory denk bodies mean alcoholic hepatitis
Characteristic finding in alcoholic hepatitis but not specific
202
Alcoholic steatofibrosis
Activation of sinusoidal stellate cells+portal fibroblasts=fibrosis (fibrosis begins with sclerosis of central veins (zone3) Scarring in a chicken wire fence pattern Laennec cirrhosis with continuous use due to developing modularity and progressive inter webbing of the scare Liver is large, brown, shrunken and non fatty Closer to cirrhosis =less likely to regress
203
Alcoholic steatlfibrosis scarring in chicken wore fence pattern
Fibrosis spreads outward and encircles individual or small clusters of hepatocytes
204
Acloholic steatofibrosis laennec cirrhosis with continuous use due to developing modularity and progressive inter-webbing of the scares
Classic micro nodular cirrhosis first described for end stage alcoholic liver disease Cirrhosis==chronic liver disease; laennec (aka micro nodular)==chicken-wire==alcoholic steatofibrosis Large bands of fibrous tissue surrounding nodules
205
Risk factors for developing alcoholic cirrhosis
10-115% of alcoholics develop cirrhosis Females are more susceptible African American>caucasion Iron overload, HBV, HCV=increased severity of liver disease
206
Mutation for alcohol intolerance
Homozygous ALDH*2 (asians) has alcohol intolerance Flushing, nausea, lethargy
207
Hepatocellular steatosis pathogenesis
Impaired lipoprotein assembly and secretion Increased peripheral catabolism of fat-> release of free fatty acids into the circulation Shunting of substrates away from catabolism and towards lipid biosynthesis (due to increased NADH production by enzymes of metabolism) -alcohol dehydrogenase and acetaldehyde dehydrogenase-> increased NADH production
208
Alcoholic hepatitis pathogenesis
Acetylaldehyde induced lipid peroxidation and protein adduct formation (carcinogen) Induced CYP450-increases conversion of other agents to form potentially toxic metabolites Impaired methionine metabolism Release of bacterial endotoxin (LPS) Release of endothelin1 Decreased perfusion of hepatic sinusoids
209
Effect of impaired methionine metabolism
Decreases glutathione levels that are normally protective of ROS
210
What happens when alcohol causes the release of bacterial endotoxin (LPS)
Pro inflammatory Estrogen increases gut permeability to endotoxin (LPS)->increased expression of the LPS receptor (CD14, TLR4) in kupffer cells==women are more sensitized to pro inflammatory effects
211
Alcoholic liver disease pathogenesis
Chronic disorder of steatosis, hepatitis, progressive fibrosis and deranged perfusion Due to an agent that was initially only marginally harmful
212
Clinic hepatic steatosis
Hepatomegaly Mild increase of serum bilirubin and alkaline phosphatase levels Severe dysfunction Is rare
213
Alcoholic liver disease clinical
AST:ALT>2:1 90% 5 year survival with abstinence in patients free of jaundice, ascites, or hematemesis 50-60% 5 year survival in patients that do not discontinue use
214
Alcoholic hepatitis clinical
Increased bilirubin, alkaline phosphatase and aserum aminotransferase Neutrophilic leukocytosis Nonspecific symptoms: malaise, anorexia, weight loss, abdominal discomfort Follows a bout of heavy drinking
215
Treatment alcoholic hepatitis
Cessation of alcohol+adequate nutrition may slowly clear disease
216
Each bout of alcoholic hepatitis has a _% risk of death
10-20
217
If a patient with alcoholic hepatitis refrains from alcohol can they still progress to cirrhosis
Yup
218
_% of people with alcoholic hepatitis progress to cirrhosis without treatment
1/3
219
Clinical alcoholic cirrhosis
Hepatic dysfunction: increased aminotransferase, bilirubin, alkaline phosphatase, hyperproteinemia (globulins, albumin, clotting factors) Anemia May be clinically silent Generally irreversible
220
End stage alcoholic hepatitis
Hepatic coma Massive GI hemorrhage Intercurrent infection(predisposed to infection) Hepatorenal syndrome after bout with hepatitis Hepatocellular carcinoma
221
What is the most common cause of chronic liver disease in the USA
Non alcoholic fatty liver disease
222
Non alcoholic fatty liver disease
Spectrum of disorders with hepatic steatosis Patients consume<20g alcohol/week 80gm/day of alcohol is considered the threshold for the development of alcoholic liver disease
223
Risk factors for non alcoholic fatty liver disease
Increased incidence due to increased obesity and the association with metabolic syndrome Contributes to progression of other liver disease (HBV, HCV) Increased risk of hepatocellular carcinoma Hispanic>african American>caucasion
224
Two hit model of non alcoholic fatty liver disease
Insulin resistance leads to hepatic steatosis Hepatocellular oxidative injury leads to liver cell necrosis and inflammatory reactions
225
What factors can lead to hepatic steatosis, obesity, and insulin resistance
Increased high calorie food intake, high fructose corn syrup, decreased exercise, genetic predisposition
226
How does metabolic syndrome lead to nonalcoholic fatty liver disease
Dysfunctional adipose tissue (endocrine organ), decreased production of adiponectin, increased TNFa, IL6=hepatocyte apopotosis
227
Why get apoptosis with non alcoholic fatty liver disease
Oxidative damage to mitochondria and plasma membranes
228
Mitochondria and non alcoholic fatty liver disease
Oxidative damage Further damaged by decreased autophagy and formation of mallory denk bodies
229
Scar tissue non alcoholic fatty liver disease
Scar tissue deposition due to kupffer cells, TNF-a, TGF-b which activates stellate cells (which are also activated through the hedgehog signalling pathway
230
Level of __ __ activity correlated with the stage of fibrosis in non alcoholic fatty liver disease
Hedgehog pathway
231
Morphology non alcoholic liver disease
Pathological steatosis=involvement of >5% of hepatocytes Overlaps with histology of alcoholic hepatitis, but - mononuclear cells more prominent - portal fibrosis more prominent - mallory denk less common 90% of cryptogenic cirrhosis is not considered “burned out” non alcoholic fatty liver disease
232
Morphology children non alcoholic fatty liver disease
Diffuse steatosis and portal fibrosis Portal+parenchymal infiltrate parenchymal neutrophils
233
Clinical non alcoholic fatty liver disease
Usually asymptomatic or have nonspecific symptoms with RUQ pain Increase AST, ALT—liver dysfunction D
234
Diagnosis non alcoholic fatty liver disease
Liver biopsy
235
Most common cause of death with non alcoholic fatty liver disease
Cardiovascular death
236
What is non alcoholic fatty liver disease associated with
Obesity and diabetes
237
What will liver biopsy show non alcoholic fatty liver disease
Pattern will be microvesicular steatosis, with large lipid vacuoles filling hepatocytes
238
Treat non alcoholic fatty liver disease
Correct obesity, hyperlipidemia, insulin resistance | -address the underlying metabolic syndrome
239
WHO criteria for diagnosis of the metabolic syndrome
One of: diabetes mellitus, impaired glucose tolerance, impaired fasting glucose, or insulin resistance Two of: BP>140/90 TG>1.695 and HDL.9 (male) >.85 (female) or BMI>30 Microalbuminuria: urinary albumin excretion>20 or albumin: Cr>30
240
Hemochromatosis
Excessive iron absorption deposited in parenchymal organs such as the liver and pancreas followed by heart, joints, and endocrine organs
241
How get hemochromatosis
Hereditary or due to excessive intake (secondary)
242
Hereditary hemochromatosis
Slow progression with symptoms appearing in 4th-5th decades for males, later (if ever) for females due to menstruation until menopause - iron accumulation is lifelong - injury caused be excess iron is slow and progressive
243
Secondary (acquired) hemochromatosis
Most common cause is associated with ineffective erythropoiesis (severe thalassemia and myelodysplastic syndrome)-excessive iron from transfusion+increased absorption Transfusions, when given repeatedly over a period of years (ie. patients with chronic hemolytic anemia)->systemic hemosiderosis and parenchymal organ injury Chronic liver disease->loss of hepatocyte mass->impaired hepcdin production_>increased iron uptake from the gut->iron overload
244
Fully developed , severe hemochromatosis
Micronodular cirrhsosis in all patients Diabetes mellitus in 75-80% Abnormal skin pigmentation in 75-80%
245
Hereditary hemochromatosis cause
Mutation in the HFE gene, whose product is involved in intestinal iron uptake by its effects on hepcidin levels
246
What do we se with hereditary hemochromatosis
Intestinal absorption of dietary iron is abnormal Net accumulation of .5-1g/yearmanifests with accumulation 20g One of the msot comon genetic disorders in humans
247
Iron toxicity hemochromatosis
Lipid peroxidation cia iron-catalyze ROS Stimulation of collagen formation by activation of hepatic stellate cells Interaction of ROS and Fe itself with DNA leads to lethal cell injury and predisposition to hepatocellular carcinoma
248
Is iron toxicity in hemochromatosis reversible
If cells not fatally injured
249
How treat iron toxicity hematochromatosis
Removal of excess iron promotes recovery of function
250
Hepcidin
Main regulator of iron absorption
251
Action of hepcidin
Lowers plasma iron levels
252
Hepcidin binds __ and internalized the transport channel, preventing iron from leaving intestinal cells and macrophages
Ferroportin
253
Transcription of hepcidin is increased by:
Inflammatory cytokines and iron
254
Transcription of hepcidin is deacreased by :
Iron defiency, hypoxia, and ineffective erythropoiesis
255
Deficient hepcidin
Iron overload
256
Mutations in hepcidin
Hemochromatosis
257
What is the most common cause of adult hemochromatosis
HFE mutation(C282Y>H63D) Chromosome 6, near an HLA locus
258
What does HFE mutation of hepcidin cause
Adult form of hemochromatosis
259
What does HFE mutation C282Y cause
Inactivation of HEF->inactivation/defiency of hepcidin->hemochromatosis
260
Who gets C282Y
White population
261
Penetrance C282Y
Low penetrance
262
H63D hepcidinmutation(less common than C282Y) who gets it
Worldwide distribution
263
TFR@ hepcidin mutation
Less common
264
Hepcidin mutation HJV or HAMP
Juvenile hemochromatosis | -more severe form of the disease than the adult variety
265
Hemochromatosis liver
Deposition of hemosiderin in liver, seen with Prussian blue stain Golden yellow hemosiderin granules initially form, and fibrous septa slowly develop Leads to small, shrunken liver micronodular cirrhosis Iron is directly hepatotoxic and there is no inflammation Late stages the liver is dark brown black due to iron accumulation
266
Hemochromatosis pancreas
Deposition of hemosiderin, seen with Prussian blue stain Intensely pigmented Diffuse interstitial fibrosis Parenchymal atrophy Hemosiderin in islet and acinar cells
267
Hemochromatosis heart
Enlarger with hemosiderin granules in myocardial fibers-> striking brown coloration Delicate interstitial fibrosis
268
Hemochromatosis skin
Pigmentation due to increased melanin production causing a gray slate color Some due to hemosiderin deposition in dermal macrophages and fibroblasts Mechanism is unknown
269
Hemochromatosis acute synovitis
Leads to pseudo gout from calcium pyrophosphate deposition
270
Hemochromatosis testes
Small, atrophic testes due to hypothalamic pituitary axis disruption and decreased hormone production
271
Clinical tetras hemochromatosis
Hepatomegaly, abnormal skin pigmentation (espicially in sub exposed areas), deranged glucose homeostasis or DM due to destruction of pancreatic islet cells and cardiac dysfunction (arrhythmia, cardiomyopathy) Atypical arthritis Hypogonadism
272
Who gets hemochromatosis
Males over 40
273
What do people with hemochromatosis have high risk for
200x increased risk of hepatocellular carcinoma
274
Does treatment of iron overload in hemochromatosis remove risk of cancer
Not fully bc DNA alterations that occur prior to time of diagnosis and initiation fo treatment
275
Diagnose hematochormis
Diagnosible long before irreversible tissue damage occurs Look for iron in the tissues with Prussian blue -Prussian blue stains hepatocellular iron blue Screen for high levels of serum iron and ferritin Screen family members
276
Screening hematochromatosis
Diagnosis can be made before irrreversible tissue damage occurs Screen for very high levels of serum iron and ferritin, exclusion of secondary causes or iron overload and liver biopsy if still in doubt
277
Heterozygous hematochromatosis
Still accumulate excess iron, but not to a level that causes significant tissue damage
278
Treat hematochromatosis
Regulat phlebotomy (blood letting) depletes tissue stores or iron=normal life expectancy
279
Neonatal (congenital) hemochromatosis
Severe liver disease and extrahepatic hemosiderin deposition of unknown origin
280
Is neonatal hemochromatosis inherited
No
281
Why get neonatal hemochromatosis
Liver injury occurs in utero; may be due to materanla alloimmune injury to fetal liver Extrahepatic hemosiderin deposition (buccal) has to be documented for proper diagnosis
282
Treat for neonatal hemochromatosis
No treatment, supportive care and possible liver transplant
283
Wilson disease mutation
AR disorder via ATP7B
284
Wilson disease problem
Impaired shopper excretion into bile and failure to incorporate copper into ceruloplasmin which leads to toxic levels of copper in the liver, kidney and eye (also kidney, bones, joints)
285
Pathogenesis wilson
Copper absorption and delivery to the liver is normal but excretion into bile is reduced, it is not incorporated into ceruloplasmin and ceruloplasmin secretion into the blood is inhibited Copper accumulated in the liver cause injury via ROS Non ceruloplasmin bound copper spills into circulation leads to hemolysis and pathology elsewhere
286
Why does copper cause toxic liver damage
Promotes formation of free radicals by the Fenton reaction Binds to sulfhydral groups of cellular proteins Displaces other metals from hepatic metalloenzymes
287
Morphology Wilson’s disease
Fatty change Acute and chronic hepatitis with Mallory denk bodies Eventually leads to cirrhosis +/- necrosis CNS toxicity: basal ganglia atrophy and cavitation Kayser-fleischer rings:green brown copper deposits in descent membrane Can use rhodamine or orcein stains to look for the copper
288
In Wilson’s there is __ urinary excretion of copper and _ plasma ceruloplasmin
Elevated Low
289
How does wilson present
Acute or chronic liver disase that presents between 6-40 years Neurological involvement: movement disorders or rigid dystonia (may be confused with parkinsonism)
290
Copper toxicity(wilson) primarily impacts the __ __, espicially the ___
Basal ganglia Putamen
291
Huntington signs
Poor coordination, chorea, or choreathetosis
292
Parkinson sign
Spastic dystonia, mask life fancies, rigidity, and gait disturbances
293
Psychotic symptoms wilson
Land these patients in mental institutions
294
Why do people with wilsons get hemolytic anemia
Copper toxicity to RBC membranes-elevated direct bilirubin
295
Diagnosis wilson
Decreased serum ceruloplasmin Increased hepatic copper content (most sensitive and accurate) - demonstration of hepatic copper content in excess 250 microgram/gram is most helpful - increased urinary copper excretion (most specific screening test)
296
Treatment wilson
Long term chelation therapy or zinc based therapy Liver transplant if unmanageable cirrhosis develops;this is curative
297
A1 antitrypsin defiency (a1AT defiency)
AR disorder of protein folding
298
PiMM a1AT
Wild type 90% of people
299
PiZz a1AT
Most common clinically relevant genotype
300
PiZz homos
10% of the normal circulating a1-antitrypsin level
301
How does PiZz present
Very early with liver disease-a1 antitrypsin defiency is the most commonly diagnosed inherited hepatic disorder in infants and children
302
A1AT have _ serum a1-antitrypsin
Low
303
What does a1-antitrypsin do
Inhibit proteases (neutrophil elastase, cathepsin G, and proteinase 3)
304
What does a1AT defiency lead to
Pulmonary emphysema because activity of destructive proteases is not inhibited Hepatic disease(cholestasis or cirrhosis) because of hepatocellular accumulation of the misfolded protein->ER stress->ER stress (misfolded protein) response->apoptosis
305
A1AT defiency is the most commonly diagnosed inherited hepatic disorder of _ and _
Infants and children
306
Pathogenesis a1AT defiency
Mutation prevents migration of the protein from the ER to the golgi, leading to accumulation of the protein in the liver All patients with PiZz genotype accumulate protein but only10-25% develop liver disease
307
Morphology a1AT defiency
Characterized by presence of round to oval cytoplasmic globular inclusions in periportal hepatocytes (*****acidophilic, PAS(+) following diastase digestion of the liver Number of globules does not represent severity of disease Ranges from cholestasis to hepatitis to cirrhosis
308
Clinical a1AT defiency
Neonatal hepatitis+cholestasis jaundice in 10-20% of affected newborns Adolescence:present with hepatitis , cirrhosis or pulmonary disease (may regres and recur) May be silent until later in life Hepatocellular carcinoma in 2-3% of PiZz adults
309
Treat a1AT defiency
Orthotopic liver transplant (cure) In patients with pulmonary disease, the single most preventative measure is avoidance of cigarette smoking
310
Function of bile
Emulsification of dietary fat in the lumen of the gut through the detergent action of bile salts The elimination of bilirubin, excess cholesterol, xenobiotics, and other waste products that are insufficiently water soluble to be excreted into urine
311
Most of the bilirubin in the serum is what
Complexed onto albumin-unconjugated
312
Is there any bilirubin free in the plasma
Super small amount
313
Can album -bilirubin be excreted in urine
No, no matter how high the serum concentration
314
A little bit os serum bilirubin-albumin is able to diffuse into tissues, espicially in what
Into premature infants brain(erythroblastosis fetalis leading to kernicterus)
315
Normal bilirubin levels
.3-1.2 mg/dL
316
Jaundice levels of bilirubin
>2.5 mg/dL
317
Neonatal jaundice
The ability to conjugate and excrete bilirubin doesn’t occur until about 2 weeks of age It is normal and expected for newborns to go through transient phases of jaundice in the beginning of life Can be exacerbated by breastfeeding due to bilirubin-deconjugate enxymes present in milk
318
Crigler najjar syndrome 1
AR complete enzyme defiency No UGT1A1 activity Unconjugated hyperbilirubinemia
319
Prognosis crigler najjar 1
Fatal in neonatal period More severe than II
320
ARcrigler najjar II
AD, variable penetrance Decreased UGT1A1 activity Unconjugated hyperbilirubinemia
321
Prognosis criglerr najjar II
Mild clinical course with only occasional kernicterus
322
Gilbert syndrome
AR decreased UGT1A1 activity Innocuous Unconjugated hyperbilirubinemia
323
Dubin johnson
AR Mutated MRP2 Conjugated hyperbilirubinemia Innocuous Impaired excretion of bilirubin glucuronides
324
Signs of dubin johnson
Black liver Mutated canalicular MDR protein 2 Pigmented cytoplasmic globules Innocuous
325
Rotor syndrome
AR Conjugated hyperbilirubinemia
326
Cholestasis
Impaired bile formation and flow->accumulation of bile pigment within the hepatic parenchyma
327
Signs of cholestasis
Jaundice, pruritus, skin xanthomas, malabsorption, vitamin ADEK deficiencies
328
Labs cholestasis
Characteristic elevated serum y-glutamyl transpeptidase (GGT) and alkaline phosphatase ALT and AST are normal as they indicate there has been loss of hepatocytes integrity
329
In cholestasis there is accumulation of bile pigment in the __ __ and longated green-brown plugs of bile are found in dilated bile canaliculi
Hepatic parenchyma
330
What are feathery degeneration of periportal hepatocyte (zone 1) incholestasis
Droplets of bile pigment that can be found in hepatocytes with a fine, foamy appearance
331
In in cholestasis there are __ ammlry denk bodies
Periportal
332
What are some common causes of large bile duct obstruction in adults
Extrahepatic cholelithiasis, malignancies of the biliary tree or head of the pancreas, strictures resulting from previous surgical procedures
333
Large bile duct obstruction commmon causes in kids
Biliary atresia, cystic fibrosis,choledochal cysts, and syndromes in which there are insufficient intrahepatic bile ducts
334
Treat cholestasis
Extrahepatic bile obstruction is treatment with surgery
335
Common causes of large bile duct obstruction in kids
Biliary atresia, cystic fibrosis, choledochal cysts, and syndromes in which there are insufficient intrahepatic bile ducts
336
Ascending cholangitis
A secondary bacterial infection of the biliary tree that aggravates the inflammatory injury
337
What causes ascending cholangitis
Subtotal or intermittent obstruction
338
What causes ascending cholangitis
Enteric bugs like coliforms and enterococci
339
Charcot triad of ascending cholangitis
Fever, RUQ pain, jaundice Also get chills
340
Histology ascending cholangitis
Influx of periductular neutrophils directly into the bile duct epithelial and lumen
341
Ascending cholangitis may be superimposed on the chronic process so that there is acute-on-chronic __ __
Liver failure
342
What can ascending cholangitis lead to
Suppurative cholangitis (most severe; risk of sepsis)
343
Suppurative cholangitis
Purple NT bile fills and distended bile ducts Frequently complicated by sepsis (instead of cholestasis)—sepsis is life threatening
344
How can intrahepatic bacterial infection directly cause cholestasis of sepsis
Abscess formation, bacterial cholangitis
345
How can liver cirrhosis cause cholestasis of sepsis
Ischemia related to hypotension caused by sepsis, espicially when liver is cirrhosis
346
How can circulating microbial products cause cholestasis of sepsis
Most likely to lead to the cholestasis of sepsis Most commmon form of this==canalicular cholestasis - bile plugs within predominantly ventriloquial canaliculi - associated with activation of kupffer cells and mild portal inflammation - hepatocyte necrosis is scant or absent
347
Ductular cholestasis
Dilated canals of hearing and bile duct ulcers at the interface of portal tracts and parenchyma become dilated and contain obvious bile plugs
348
Biliary cirrhosis
Due to chronic biliary obstruction and ductular reactions that lead to periportal fibrosis and eventually hepatic scarring and nodule formation There may also be bile infarcts from the detergent effects of the extravasated bile
349
Primary heptolithiasis
Disease of intrahepatic gallstone formation that leads to repeated bouts of ascending cholangitis, progressive inflammatory destruction of hepatic parenchyma, and predisposes to biliary neoplasia
350
Where is primary hepatocyte I asis common
East Asia
351
Morphology primary hepatolithiasis
Pigmented Ca bilirubinate stones in distended intrahepatic bile ducts Ducts show chronic inflammation, mural fibrosis, and peribiliary gland hyperplasia Biliary dysplasia may also be seen—>may evolve to invasive cholangiocarcinoma
352
What do people with primary hepatolithiasis have an increased risk of getting
Cholangiocarcinoma by unknown mechanism
353
Neonatal hepatitis
Liver injury/inflammation in the neonate Leads to jaundice, dark urine, light or acholic stools, hepatomegaly There may be varying levels of impaired hepatic synthetic function
354
Neonatal cholestasis
Prolonged conjugated hyperbilirubinemia in the neonate after 2 weeks (not physiological jaundice of the newborn)
355
Morphology neonatal hepatitis
* panlobular giant-cell transformation of hepatocytes - lobular disarray with local liver cell apopotosis and necrosis - hepatocellular and canalicular cholestasis - mild mononuclear infiltration of the portal areas with reactive changes in kupffer cells - extramedullary hematopoiesis
356
Biliary atresia
Complete or partial obstruction of the lumen of the extrahepatic biliary tree within the first three months of life
357
What is the most common cause of neonatal cholestasis and death from liver disease in early childhood
Biliary atresia
358
Pathogenesis of fetal biliary atresia
Associated with other anomalies resulting from ineffective establishment of laterality of thoracic and abdominal organs during development Due to aberrant intrauterine development of the extrahepatic biliary tree
359
Pathogenesis of perinatal biliary atresia
Most common 80% Destruction of the normal biliary tree shortly after birth Rotavirus, CMV, reovirus, autoimmune are all implicated Genetic basis
360
Morphology biliary atresia
Inflammatory and fibrosis stricture of the hepatic or common bile ducts Progressive destruction of the intrahepatic biliary tree
361
Clinical presentation biliary atresia
Neonatal cholestasis, but normal weight gain Normal stools change into acholic stools Jaundice lasts longer than 2 weeks
362
Serum bilirubin in biliary atresia
6-12 mg/dL
363
What happens if biliary atresia is left untreated
Leads to cirrhosis in 3-6 months after birth, death by 2
364
Treatment biliary atresia
If limited to common duct(typeI) or left/right hepatic ducts(typeII):Kauai procedure Obstruction above the porta hepatitis(typeIII): not correctable (90%) and needs liver transplant -no patent bile ducts amendable to surgical anastomsis
365
Primary biliary cirrhosis
Non-suppurative, inflammatory destruction of small/medium-sized intrahepatic bile ducts -not the large or extrahepatic ducts
366
Does primary biliary cirrhosis progress to cirrhosis
Not really
367
Primary cirrhosis shows __ __ lesions
Florid duct
368
Who gets primary biliary cirrhosis
Disease of middle aged women :40-50 year old femmes that live in Northern European countries (England Scotland) or northern US(Minnesota) North south gradient Family member with primary biliary cirrhosis
369
Morphology primary biliary cirrhosis
Anti-mitochondrial antibodies )anti-PDC-E2) Florid duct lesion: interlobular ducts are actively destroyed by lymphoplasmacytic inflammation with or without granulomas Patchy loss of the ducts Feathery degeneration and ballooned, bile stained hepatocytes with mallory denk bodies Hepatocyte loss, regenerative hyperplasia, hepatomegaly Widespread duct loss that leads to cirrhosis and periportal/periseptal cholestasis->end stage Widespread modularity without the surrounding scar tissu seen in cirrhosis (nodular regenerative hyperplasia)->portal HTN
370
How diagnose primary biliary cirrhosis
Biopsy (look for florid duct lesion)
371
Primary biliary cirrhosis causes increased serum what in the asymptomatic individual
Alkaline phosphatase and GGT
372
Clinical presentation primary biliary cirrhosis
Patients may have progressive fatigue and pruritis Secondary symptoms may appear: hyperpigmentatoin, xanthelasmas, steatorrhea, vitamin D malabsorption_>osteomalacia/osteoporosis
373
Associated systemic findings of primary biliary cirrhosis
Other autoimmune disorders; shorten syndrome (xerostomia, xeropthalmia), sclerosis, thyroiditis, rheumatoid arthritis, raynaud phenomenon, and celiac disease
374
Treat primary biliary cirrhosis
Early stage-ursodeoxycholic acid to slow progression Late stage-liver transplant (ursodeoxycholic acid is ineffective)
375
Primary sclerosing cholangitis
Inflammation and fibrosis of intrahepatic and extrahepatic bile ducts with dilation of preserved segments -see beading on radiographs
376
What do you see on radiographs with primary sclerosing cholangitis
Beading seen on radiographs
377
Who gets primary sclerosing cholangitis
More likely to affect males 20-40 yo If first degree relative has primary sclerosing cholangitis
378
Associated conditions of primary sclerosing cholangitis
IBD(ulcerative colitis) coexists win about 70% of patients with PSC May lead to biliary intraepithelial neoplasia and cholangiocarcinoma with fatal utcomes
379
__ are found in 65% of patients with primary sclerosing cholangitis
PANCAs Atypical perinuclear antineutrophillic cytoplasmic antibodies
380
Morphology large duct in primary sclerosing cholangitis
Neutrophilic infiltration of the epithelium on a chronic inflammatory backgrounf The inflammation and edema lead to obstruction and scarring that narrow the lumens
381
Smaller ducts morphology primary sclerosing cholangitis
Little inflammation with onion skin fibrosis around an atrophic duct lumen that leads to obliteration by a tombstone scar
382
What happens to the liver as primary sclerosing cholangitis progresses
The liver becomes cholestasis that can lead to primary biliary cirrhosis
383
Clinical primary sclerosing cholangitis
Persistent elevation of serum alkaline phosphatase There may be progressive fatigue pruritis and jaundice Acute bouts of ascending cholangitis Typically progresses over 5-17 years leading to cholestasis
384
Diagnosis primary sclerosing cholangitis
Radiology of the larger ducts will show strictures and beading with pruning of the smaller ducts Diagnosis is made by radiologic imaging of the biliary tree
385
Treat primary sclerosing cholangitis
No real treatment | Transplant at end stage
386
Choledochal cysts
Congenital dilation of the common bile duct
387
Who gets choledochal cysts
Present most often in kids before 10 years old as jaundice or recurring abdominal pain (symptoms of typical biliary colic) 3-4x more likely in females
388
Fibropolycystic disease
Group of different lesions int he liver due to congenital malformations of the biliary tree (ductal plate malformation)
389
Presentation fibropolycystic disease
Most are incidental findings, but can also present as hepatosplenomegaly or portal HTN without hepatic dysfunction in late childhood or adolescence
390
What is fibropolycystic disease associated with
Commonly happens in association with autosomal recessive polycystic renal disease Patients have an increased risk of cholangiocarcinoma
391
What are the 3 sets of pathological findings of fibropolycystic disease
Von meyenburg complexes Caroli disease Congenital hepatic fibrosis
392
Von meyenburg complexes
Small bile duct hamartomas that are normal if limited, but indicative of FPD if they are diffuse
393
Caroli disease
Biliary cysts in isolation that lead to clinical symptoms Carli syndrome: biliary cysts that occur with congenital hepatic fibrosis
394
Congenital hepatic fibrosis
Portal tracts are enlarged by irregular broad bands of collagenous tissue that form septa to divide the liver into irregular islands - abnormally shaped bile ducts embedded in the fibrous tissue still connected to the biliary tree - may have portal HTN as a result
395
Circulatorydisorders
Clinically significant liver function abnormalities do not always develop Hepatic morphology may be strikingly affected
396
What can compromise the hepatic artery
Liver infarcts are rare due to dual blood supply to the liver Loss of blood supply intrahepatic can lead to localized infarct that is pale or hemorrhagic Transplanted livers are more likely to become infarcted as they only have blood supple from the arterial system
397
What does hepatic artery compromise result in
Impaired blood flow to the liver
398
__ __ obstruction/thrombosis also impairs blood flow to the liver
Portal vein
399
Most common cause of impaired blood flow THROUGH the liver
Cirrhosis
400
What besides cirrhosis causes impaired blood flow through the liver
Physical sinusoidal occlusion
401
What causes physical sinusoidal occlusion
Sickle cell disease Disseminated intravascular coagulation Eclampsia Diffuse intrasinusoidal metastatic tumor
402
What may portal vein occlusions cause
Esophageal varices
403
What is the most common cause of intrahepatic blood flow obstruction
Cirrhosis
404
What is the most common cause of small portal vein branch obstruction
Schistosomiasis
405
What causes obliterating portal venopathy
HIV
406
Peliosis hepatis
Sinusoidal dilation that occurs in any condition in which efflux of hepatic blood is impeded Blood lakes (due to sex hormones, infection)
407
Right sided heart failure or terminal event
Passive congestion
408
Left sided heart failure
Hepatic hypoperfusion and hypoxia->ischemic coagulative necrosis of hepatocytes in the central region of the lobule (centrilobular fibrosis)
409
Chronic CHF
Cardiac sclerosis with centrilobular fibrosis Nutmeg liver:hypoperfusion and retrograde congestion
410
Budd chiari syndrome
Obstruction of two or more major hepatic veins that leads to hepatomegaly, pain and ascites
411
Prognosis budd chiari
High mortality
412
Morphology budd chiari
Liveris swollen red purple, and has a tense capsule There are different areas of preserved or regenerating parenchyma alternating with hemorrhagic collapse Severe centrilobular congestion and necrosis, or fibrosis if slowly developing Affected veins may contain thrombi
413
Treatment budd chiari
Surgery to create a portosystemic venous shunt permits reverse flow throug the portal vein and improves the prognosis (5 year survival>67%)
414
Sinusoidal obstruction syndrome
Obliteration of the terminal hepatic venues by subendothelial swelling and collagen deposition
415
Causes of sinusoidal obstruction syndrome
Jamaican bush tea drinkers 3 weeks after stem cell transplant Cancer patients receiving chemotherapy Toxic injury to the sinusoidal endothelium
416
Morphology sinusoidal obstruction syndrome
Centrilobular congestion, hepatocellular necrosis, and accumulation of hemosiderin macrophages Obliteration of the lumen of the venue is identified with special stains for connective tissue
417
Clinical sinusoidal obstruction syndrome
Histology=gold standard of diagnosis Clinical diagnosis=tender hepatomegaly, ascites, weight gain, jaundice
418
Passive congestion and centrilobular necrosis and liver
Hepatic manifestations of systemic circulatory compromise
419
Liver and bone marrow transplant
Graft vs host | Attack the liver
420
Liver transplant and liver
Host vs graft | Attacks the liver
421
Acute GVHD time
10-50 days
422
GVHD chronic days
100+ days
423
Acute GVDH
Donor lymphocytes attach the epithelial cells of the liver Hepatitis with necrosis or hepatocytes and bile duct epithelial cells Inflammation of the portal tracts and parenchyma
424
Chronic GVHD
Portal tract inflammation, selective bile duct destruction, and eventual fibrosis
425
Acute transplant rejection is ___ and chronic transplant rejection is ____
Cellular Vascular
426
Acute(cellular) transplant rejection
Characterized by infiltration of a mixed portal inflammatory infiltrate Associated with bile duct injury and endothelitis
427
Chronic (vascular) transplant rejection
Obliteration arteriopathy of small and large arteries leads to ischemic changes int he liver parenchyma Vanishing bile duct syndrome*
428
What are some hepatic diseasesassociated with pregnancy given that 3-5% of pregnant patients have abnormal liver function tests
Viral hepatitis (most common cause of pregnant jaundice) Hepatic complications that are directly attributable to pregnancy in .1% Preeclampsia and eclampsia
429
Viral hepatitis and pregnancy
HAV, HBV, HCV, or HBV+HBD HEV infectionruns a more severe course in pregnancy and has a mortality rate of 20%
430
Preeclampsia
Maternal HTN, proteinuria, peripheral edema, and coagulation problems
431
When does preeclampsia become eclampsia
When hyperreflexia and convulsions
432
HELLP syndrome:subclinical manifestation of preeclampsia
Hemolysis Elevated liver enzymes Low platelets (thrombocytopenia)
433
Liver in preeclampsia and eclampsia
Periportal sinusoids contain fibrin deposits associated with hemorrhage into the space of disse with associated hemorrhagic necrosis Blood presssure can lead to hematoma and may rupture
434
Clinic preeclampsia and eclampsia
Modest to severe elevation of serum aminotransferases and mild elevation of serum bilirubin
435
When does acute fatty liver of pregnancy occue
Latter half of pregnancy, often int he third trimester
436
Prognosis acute fatty liver of pregnancy
Hepatic dysfunction that can lead to hepatic failure, coma, and death in severe cases
437
In acute fatty liver of pregnancy there is elevated __
Serum aminotransferase levels
438
What are symptoms from incipient hepatic failure in acute fatty liver of pregnancy
Bleeding, nausea, vomiting, jaundice, and coma
439
Diagnosis of acute fatty liver of pregnancy
Characteristic diffuse microvesicular steatosis of hepatocytes on biopsy May be lobular disarray with hepatocyte dropout, reticulin collapse, and portal tract inflammation (looks like viral hepatitis)
440
Prognosis acute fatty liver of pregnancy
Can progress very quickly to hepatic failure and death in a few days
441
How do u treat acute fatty liver of pregnancy
Termination of pregnancy
442
Intrahepatic cholestasis of pregnancy presentation
Onset of pruritus, followed by darkening of urine and occasionally light (acholic) stools and jaundice in the 3rd trimester
443
Labs intrahepatic cholestasis of pregnancy
Serum bilirubin and alkaline phosphatase may be slightly elevated Bile salt levels are greatly increased
444
Prognosis intrahepatic cholestasis of pregnancy
Generally a benign condition to mother Incidence of fetal distress, stillbirth, and prematurity is moderately increased
445
Nodule hyperplasia of the liver (not a true neoplasm)
Single or multiple nodules may develop n a non cirrhosis liver either from focal nodular hyperplasia or nodular regenerative hyperplasia
446
What causes nodular hyperplasia of the liver
Due to focal or diffuse alterations in hepatic blood obliteration of portal vein radicle and compensatory flow of arterial blood supply
447
What is focal nodular hyperplasia
Benign;well demarcated but poorly encapsulated Spontaneous mass lesion that appears in a normal liver
448
Who gets focal nodular hyperplasia
Young to middle aged adults
449
Morphology focal nodular hyperplasia
Tighter than the surrounding liver and is sometimes yellow from steatosis Central grey-white depressed stellate scar (containing vessels with fibromuscular hyperplasia) that fibrous septa radiate outward from
450
Nodular regenerative hyperplasia
Entire liver is transformed into nodules, looks similar to focal nodular hyperplasia, but there is no fibrosis
451
Wha can nodular regenerative hyperplasia lead to
Portal HTN
452
What is nodular regenerative hyperplasia associated with
Conditions that affect intrahepatic blood flow like HIV or autoimmune
453
Symptoms nodular regenerative hyperplasia
Usually asymptomatic, only found at autopsy
454
Morphology nodular regenerative hyperplasia
Plump hepatocytes are surrounded by rims of atrophic hepatocytes
455
What is the most common benign liver tumor
Cavernous hemangiomas
456
Cavernous hemangiomas are tumors of the ___ ___
Blood vessels
457
Morphology cavernous hemangiomas
Red blue nodules located directly under the capsule Vascular channels in a bed of fibrous CT
458
Are cavernous hemangiomas more common in males or females
Females
459
How find cavernous hemangiomas
Found incidentally or after hemorrhage | -might be mistaken radiographically or intraoperatively for metastatic tumors
460
What are hepatocellular adenomas
Benign neoplasm developing from hepatocytes
461
Rupture of hepatocellular adenoma
Intrabdominal bleeding that is a surgical emergency
462
What are hepatocellular adenomas associated with
Oral contraceptive therapy and anabolic steroids (so sex hormones) -HEPATOCELLUAR ADENOMAS WERE UNKNOWN BEFORE THE ADVENT OF ORAL CONTRACEPTIVES
463
What are the three types of hepatocellular adenomas
HNF1-a inactivated adenomas B-catenin activated adenomas Inflammatory adenomas
464
HNf1-a inactivated adenomas are associated with what
MODY-3
465
Risk of malignant transformation with HNF-1-a inactivated adenomas
No risk of malignant transformation
466
Describe HFN1-a inactivated adenomas
Fatty with no atypia Look for NO staining with liver fatty acid binding protein (LFABP)
467
b catenin activated adenomas associated with what
Use of oral contraceptives and anabolic steroids (so sex hormones)
468
B catenin activated adenomas risk of malignant transformation
Very high
469
Describe b catenin activated adenomas
High degree of dysplasia | Look for glutamine synthetase diffusely and b catenin in the nucleus
470
Inflammatory adenomas associated with what
NAFLD Mutations in gp130 (IL6, JAK-STAT pathway)
471
Inflammatory adenomas risk of malignant transformation
Small, but definite risk of malignant transformation
472
Describe inflammatory adenomas
Characteristically have in addition areas of fibrotic stroma, mononuclear inflammation, ductular reactions, dilated sinusoids, and telangiectatic vessels Over express CRP and serum amyloid A
473
What is the most common liver tumor of early childhood
Hepatoblastoma
474
What are the types of hepatoblastoma
Epithelial Mixed epithelial and mesenchymal type
475
Epithelial type of hepatoblastoma
Small polygonal fetal cell or smaller embryonal cells forming acini, tubules, or papillary structures vaguely looking like liver development
476
Mixed epithelial and mesenchymal type of hepatoblastoma
Foci of mesenchymal differentiation with osteoporosis, cartilage, or striated muscle
477
Hepatoblastoma frequently activates ___ pathway
``` WNT pathway (APC mutation) *patients with familial adenomatous polyposis frequently develop hepatoblastoma ```
478
What are hepatoblastoma associated with
Familial adenomatous polyposis and beckwith-wiedemann syndromes
479
What is the most common primary malignancy of hepatocytes
Hepatocellular carcinoma
480
Risk factors for hepatocellular carcinoma
HBV in Asian countries, HCV in USA (both turn chronic) Alcohol, AFLATOXIN, a1AT, hemochromatosis, NAFLD, wilson disease, adenomas
481
Genetic factors for hepatocellular carcinoma
B catenin activation and p53 inactivation (aflatoxin) are the two most common mutational events May be associated with Il-6/HNF4-a
482
Hepatocellular carcinoma low grade dysplastic nodules: precursor lesion
No atypia, have a higher risk of becoming high grade nodules Shown to be colonial and are probably neoplastic
483
Hepatocellular carcinoma high grade dysplastic nodules:precursor lesions
Signs of atypia, have a great risk of becoming HCC and HCC foci are often found already in nodules
484
What is the most important pathway for emergence of HCC in viral hepatitis and alcoholic liver disease****
High grade dysplastic nodules
485
Hepatocellular carcinoma morphology large cell change
Scattered hepatocytes near portal tracts or septa that are larger than normal hepatocytes with large multiple pleomorphic nuclei Nuclear cytoplasmic ratio is normal Large cell change is a marker of increased risk of hepatocellular carcinoma-considered directly pre malignant in hepatitis B
486
Hepatocellular carcinoma small cell change morphology
High nuclear cytoplasmic ration and mild nuclear hyperchromasia/pleomorphism Hepatocytes will commonly form tiny nodules within a single parenchymal lobule Directly premalignant
487
Hepatocellular carcinoma may appear as what morphologically
Large univocal mass Multifocal, widely distributed nodules Diffusely infiltration cancer
488
Hepatocellular carcinoma intrahepatic metastases
By either vascular invasion or direct extension, become more likely once tumors reach 3 cm in size
489
Hepatocellular carcinoma small, satellite tumor nodules are around what
The larger, primary masss
490
Hepatocellular carcinoma vascular metastasis
The most likely route for extrahepatic metastasis, espicially by the venous system
491
Hepatocellular carcinoma hematogenous metastases
Espicially to the lung, tend to occur late in the disease
492
Presentation of hepatocellular carcinoma
Common liver dysfunction symptoms and hepatomegaly
493
_% of patients with advanced hepatocellular carcinoma have elevated a-fetoprotein. What does this mean
50 Insensitive as a screening test for pre malignant or early lesions
494
Diagnosis hepatocellular carcinoma
Imaging
495
What causes death hepatocellular carcinoma
Cachexia, GI or varices bleeding, liver failure, or rarely from tumor rupture and hemorrhage
496
Prognosis hepatocellular carcinoma
Die in 2 years
497
Fibrolamellar carcinoma
Rare variant of hepatocellular carcinoma
498
Who gets fibrolamellar carcinoma
<35
499
Presentation fibrolamellar carcinoma
Single large hard scirrhous tumor with fibrous bands coursing through it
500
What is a fibrolamellar carcinoma composed of
Well differentiated cells rich in mitochondria growing in nests or cords separated by parallel lamellae of dense collagen bundles
501
Cholangiocarcinoma
Second most common primary malignant tumor after HCC Cancer of the biliary tree coming from bile ducts within and outside the liver Adenocarcinoma
502
Risk factor for cholangiocarcinoma
Liver flukes (opisthorchis, clonorchis) Chronic inflammation of the large bile ducts HBV, HCV, NAFLD (same as HCC)
503
Extrahepatic cholangiocarcinoma
Perihilar tumors (klaskin tumors) located at the junction of the hepatic ducts (most common) Common bile duct, posterior to the duodenum
504
Intrahepatic cholangiocarcinoma
Only 10% of tumors
505
Premalignant lesion of cholangiocarcinoma
Biliary intraepithelial neoplasia (low to high grade: Bi1IN-1,2,3) 3 is the highest grade and has the highest risk of malignant transformation
506
Morphology extrahepatic cholangiocarcinoma
Form grey nodules in the bile duct wall that can be diffuse to papillary Generally small lesions at the time of diagnosis
507
Intrahepatic morphology cholangiocarcinoma
Track along the intrahepatic portal tract system that creates a branching tumor within a portion of the liver
508
Cholangiocarcinomas are __ differentiated with __/__ structures lined by __ epithelial cells
Moderately well Glandular/tubular Epithelial
509
Prognosis cholangiocarcinoma
Median time to death is 6 months for intrahepatic, but overall for any location is 14% 2 year survival
510
Clinical presentation intrahepatic cholangiocarcinoma
Present as obstruction to bile flow or symptomatic liver mass
511
Clinical presentation of extrahepatic cholangiocarcinoma
Biliary obstruction , cholangitis, and RUQ pain
512
Combined hepatocelular and cholangiocarcinoma
Suggest an origin from a multipotent stem cell
513
Mutinous cystic neoplasms and intraductal papillary biliary neoplasia
May occur as in situation lesion or as invasive cholangiocarcinoma
514
Angiosarcoma
Has historic association with vinyl chloride, arsenic, or thorotrast
515
Hepatic lymphomas. Who gets is
Middle aged men
516
What are hepatic lymphomas associated with
HBV, HCV, HIV< PBC
517
Describe hepatic lymphoma
Most are diffuse large B cell lymphomas, then MALTomas
518
Hepatosplanic delta-gamma T cell lymphoma, who get is
Young adult males
519
Hepatosplenic delta-gamma T cell lymphoma is a predilection for
Hepatic and splenic sinusoids as well as the marrow
520
Is metastases or primary liver cancer more common
Metastases
521
Most common places that metastases to the liver
Colon, breast, lung, pancreas
522
How does metastases to the liver present
Appear as multiple nodular metastases that replace most of the parenchyma and lead to hepatomegaly, but can also appear as just a single nodule Usually clinically silent until late stage
523
What is the most common congenital gallbladder anomaly
A fundus that is folded inwards, creating a phrygian cap
524
More than 95% of biliary tract disease is attributable to ___
Cholelithiasis
525
Cholelithiasis
Stones of either cholesterol or pigment (bilirubin) that collect in the gallbladder
526
Why are cholesterol stones more common in developed countries and pigment stones more common in developing countries: cholelithiasis
Diet Infections
527
Risk factors for cholelithiasis
Middle to older age female Obesity, metabolic syndrome Estrogen exposure (OC, pregnancy) Native Americans Gallbladder stasis ABCG8 variant (ABC transport)
528
Pathogenesis for cholesterol cholelithiasis
Collect when their concentration increases above the capacity of the bile-precipitate out of bile Can happen when there is too much cholesterol, crystal nucleation, mucus secretion, or hypomotility Cholesterol stones are more common in the US and western countries-probably do to diet
529
Pathogenesis of pigment stones
Stones of unconjugated bilirubin and inorganic calcium salts Can happen when there are elevated levels of unconjugated bilirubin in the bile - chronic hemolytic anemia - severe ideal dysfunction or bypass - bacterial contamination of the biliary tract leading to release of beta-glucuronidases(e coli, ascaris, lumbricoides, liver fluke c sinensis) Arise primarily in te setting of bacterial infections of the biliary tree and parasitic infestations
530
Cholesterol stones morphology
In gallbladder Pure cholesterol stones look pale yellow, finely granular, hard, crystalline palisade - stones composed largely of cholesterol are radiolucent - sufficient calcium carbonate renders 10-20% of them radiopaque - BECOME MORE BLACK and are more lamellated when they are mixed with other substances
531
Pigment stones morphology
Black stones are found in sterile bile ducts and are made up mostly of bilirubin, salts, and mucin. Appear friable with speculated and molded contours 50-70% of black stones are radioopaque due to calcium salts Brown stones are found in infected large bile ducts ; composition is the same, but also have some cholesterol mixed in and are found in ducts with infections. Soap like, greasy, soft, laminated -radiolucent because they contain calcium soaps
532
Clinical presentation gall stones
Usually asymptomatic Biliary colic=excruciating constant pain Pain in RUQ that radiates to the right upper shoulder or the back, which is worse after a fatty meal***
533
With cholesthiasis , large stones are less likely to enter the cystic or common ducts and produce obstruction
Small stones (gravel) are more dangerous Gallstones ileus/bouveret syndrome: when a large stone erodes directly into an adjacent loop of small bowel and generates intestinal obstruction
534
Primary complication of gallstones
Acute cholecystitis
535
Acute calculous cholecystitis
From chemical irritation and inflammation from a stone - absence of bacterial infection (though one may develop later in the course) - 90% of the time caused by obstruction of the neck or cystic duck by a stone - most common reason for an emergency cholecystectomy
536
Acute acalcuous cholecystitis
May occur in severely ill patients - accounts for the other 10% - frequently develops in diabetic patients who have symptomatic gallstones - though to result from ischemia (cystic artery=end artery) - primary bacterial infection 9salmonella typhi and staphylococci) - incidence of gangrene and perforation is much higher in acalculous that’s in calculous
537
Risk for acute cholecystitits
Sepsis with hypotension and multisystem organ failure, inspired, major trauma and burns, diabetes, infections
538
Morphology acute cholecystitis
Gallbladder is enlarged and tense, may be green-black, bright red, or blotchy Serosa covering is typically covered in a fibrous exudate In calculous cholecystitis, the stone is blocking the exit and causes the lumen to fill with cloudy or turbid material that may contain fibrin
539
Gallbladder empyema
When the exudate is virtually pure pus
540
Mild gallbladder empyema
Wall is thickened, edematous, and hyperemic
541
Severe gallbladder empyema
Wall is green-black and necrotic (gangrenous cholecystitis)
542
Acute emphysematous cholecystitis
When the gallbladder is invaded by gas forming organisms (clostridium and coliforms)
543
Acute emphysematous cholecystitis
When the gallbladder is invaded by gas forming organisms
544
Clinical acute cholecystisis
Most patients have experienced pain before the acute attack The acute attack: progressice pain in the RUQ or epigastric that lasts longer than 6 hours Mild fever, anorexia, tachycardia, sweating, nausea, and vomiting
545
Acute cholecystitis bilirubin and alkaline phosphatase
Slightly elevated
546
What does hyperbilirubinemia in acute cholecystisis cause
Obstruction of the common bile duct
547
Treat acute cholecystisis
25% will need surgery, other patients will recover in 10 days
548
There is a greater risk of __ and __ in patients that have acalculous cholecystitis
Gangrene Perforation
549
Chronic cholecystisi
Chronic inflammation of the gallbladder that is due to stones in 90% of the time Can be due to repeated acute attacks, but many times is not At risk population is the same as that for cholelithiasis
550
Morphology chronic cholecystitis
Serosa may be dulled to subserosal/subepithelial fibrosis Wall is variably thickened, has a grey white appearance Reactive proliferative may lead to fusion of the mucosal folds and give rise to buried crypts of epithelial in the gallbladder
551
Rokitansky-aschoff sinus cholecystisis
Outpouching of the mucosal epithelium through the wall | -diverticulum of the gallbladder
552
Porcelain gallbladder chronic cholecystitis
Rare calcification of the wall that increases the risk of developing cholangiocarcinoma
553
Xanthogranulomatous cholecystisis chronic cholecystisis
Very thick wall and the gallbladder is shrunken, nodular with foci of necrosis and hemorrhage that was triggered by rupture of R-A sinuses. Leads to foam (xanthoastrocytoma) cells
554
Hydrops of the gallbladder chronic cholecystitis
Atrophic, chronically obstructed, often dilated gallbladder that may contain only clear secretions
555
Clinical chronic cholecystitis
Recurring acute symptoms with intolerance for fatty foods Beware of bacterial secondary infections, perforation, fistula, and obstruction
556
What is the most common malignancy of the extrahepatic biliary tract
Adenocarcinoma of the gallbladder
557
Who is at risk for carcinoma of the gallbladder
Women Chile, Bolivia, northern India, south western ethnic US population HAVING GALLSTONES
558
Pathogenesis gallbladder carcinoma
Biggest risk factor is having gallstones, 1-2% of stone patients get cancer 95% of gallbladder cancers arise in the setting of gallstones Though that chronic inflammation is reason cancer comes
559
Morphology carcinoma of the gallbladder infiltrating
Poorly defined area of mural thickening and induration | More common
560
Morphology carcinoma of gallbladder exophytic
Grows intot he lumen (and invades the underlying wall)
561
Is exophytic or infiltrating carcinoma of gallbladder associated wth better prognosis
Exophytic
562
Is infiltrating or exophytic more common carcinoma of gallbladder
Infiltrating
563
In gallbladder carcinoma, deep ulceration can lead to what
Fistula penetration into other viscera
564
In carcinoma of gallbladder, what does it commonly seed
Cystic duct, adjacent bile ducts, portal hepatic lymph nodes, peritoneum, GI tract and lungs
565
When is most gallbladder carcinoma found
At surgery when he gallbladder is though to have stones
566
What are presenting symptoms of gallbladder carcinoma
Same as those for cholelithiasis: abdominal pain, jaundice, anorexia, nausea, vomiting
567
When galll bladder carcinoma is found, what is the prognosis, most of which is already advanced
5 years survival is <10%
568
____ oncoprotein is overexpressed in 33-67% of cases of gallbladder carcinoma
ERBB2 (Her-2/neu)